PHASE-II EVALUATION OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDINE (AMSA) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCERS

被引：0

作者：

RATANATHARATHORN, V

DRELICHMAN, A

SEXONPORTE, M

ALSARRAF, M

机构：

[1] WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI 48201

[2] HARPER HOSP,DETROIT,MI 48201

[3] GRACE HOSP,DETROIT,MI 48201

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：29 / 32

页数：4

共 50 条

[31] SUCCESSFUL TREATMENT OF A PATIENT WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA (ANLL) AND ANTHRACYCLINE CARDIOMYOPATHY WITH 4'(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (AMSA)
FANUCCHI, MP
ARLIN, ZA
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 10 (01) : 27 - 28
[32] PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE (NSC 249992) IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA
TAN, CTC
HANCOCK, C
STEINHERZ, PG
STEINHERZ, LJ
SORELL, M
CHAN, KW
MONDORA, A
MILLER, DR
CANCER RESEARCH, 1982, 42 (04) : 1579 - 1581
[33] ENHANCEMENT OF VIRAL GROWTH BY THE ANTI-TUMOR DRUG 4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE (M-AMSA)
DRAKE, S
FURLONG, NB
NELSON, JA
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (17) : 2615 - 2618
[34] PHASE-II TRIAL OF (META-AMSA) 4'-9-(ACRIDINYLAMINO)-METHANESULFON-META-ANISIDE IN PRIMARY LIVER-CANCER
CHENG, E
LIGHTDALE, C
YOUNG, C
YAGODA, A
FORTNER, J
GOLBEY, R
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02): : 211 - 213
[35] BILIARY-EXCRETION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN RATS - EFFECTS OF PRETREATMENT WITH DIETHYL MALEATE, PHENOBARBITAL, AND METYRAPONE
SHOEMAKER, DD
GORMLEY, PE
CYSYK, RL
DRUG METABOLISM AND DISPOSITION, 1980, 8 (06) : 467 - 468
[36] INVITRO CHEMOSENSITIVITIES OF HUMAN-TUMOR STEM-CELLS TO THE PHASE-II DRUG 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE AND PROSPECTIVE INVIVO CORRELATIONS
AHMANN, FR
MEYSKENS, FL
MOON, TE
DURIE, BGM
SALMON, SE
CANCER RESEARCH, 1982, 42 (11) : 4495 - 4498
[37] HYDROXYUREA (HU), 4'-(9-ACRINDINYLAMINO)METHANESULFON-M-ANISIDINE (AMSA) SYNERGY AGAINST BROWN NORWAY MYELOCYTIC-LEUKEMIA (BNML) INVIVO
VAUGHAN, WP
CLINICAL RESEARCH, 1985, 33 (02): : A460 - A460
[38] A PHASE-II STUDY OF 4'-9-ACRIDINYLAMINO-METHANE-SULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH METASTATIC LUNG-CANCER
MURPHY, WK
VALDIVIESO, M
LEGHA, S
BODEY, GP
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 456 - 456
[39] PHASE-II STUDY OF 4'-(9-ACRIDINYL-AMINO) METHANESULFON-M-ANISIDIDE (AMSA) IN METASTATIC MELANOMA
LEGHA, SS
HALL, SW
POWELL, KC
BURGESS, MA
BENJAMIN, RS
GUTTERMAN, JU
BODEY, GP
CANCER CLINICAL TRIALS, 1980, 3 (02) : 111 - 114
[40] THE PRODUCTION OF TOPOISOMERASE-II-MEDIATED DNA CLEAVAGE IN HUMAN-LEUKEMIA CELLS PREDICTS THEIR SUSCEPTIBILITY TO 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (M-AMSA)
BAKIC, M
BERAN, M
ANDERSSON, BS
SILBERMAN, L
ESTEY, E
ZWELLING, LA
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 638 - 645

← 1 2 3 4 5 →